てんかんモニタリングデバイス市場

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2021年10月

てんかんモニタリングデバイス市場：技術（火器管制システム、兵器システム、対策システム、コマンド、制御システム）、範囲（短、中、長）、脅威の種類、ドメイン（地上、空中、海上、宇宙）、地域別 – 2026年までの予測

Epilepsy Monitoring Devices Market by Product (Conventional & Wearable Devices, Standard EEG, Video EEG, Ambulatory EEG, EMG, MEG, Deep Brain Stimulation Devices) End User (Hospitals, Neurology Centres, ASC, Home Care Settings) – Global Forecast to 2026

–

–

The global epilepsy monitoring devices market is projected to reach USD 615 million by 2026 from USD 489 million in 2021, at a CAGR of 4.7% during the forecast period. The growth in this market is driven by the increasing incidence and prevalence of epilepsy, growing preference for ambulatory healthcare and increasing use of wearables, growing demand for continuous monitoring, and the rising awareness of neurodegenerative diseases, including epilepsy. On the other hand, the high cost of complex epilepsy monitoring procedures and devices and the unfavorable reimbursement policies are restraining the growth of this market.

“The conventional devices segment accounted for the largest share of the epilepsy monitoring devices market in 2020.”
Based on products, the epilepsy monitoring devices market has been segmented into wearable devices and conventional devices. The large share of this segment is attributed to rising awareness of neurodegenerative diseases including epilepsy.

“The market in Asia Pacific is projected to witness the highest growth rate during the forecast period (2021–2026).”
North America accounted for the largest share of the epilepsy monitoring devices market in 2020. The high incidence of neurological disorders, a growing number of clinical trials for epilepsy monitoring devices, and a large number of end users in the US account for their larger market shares.

A breakdown of the primary participants referred to for this report is provided below:
•By Company Type (Supply-side): Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
•By Designation: C-level: 35%, Director-level: 25%, and Others: 40%
•By Region: North America: 45%, Europe: 30%, Asia-Pacific: 20%, and RoW: 5%
The major players in the Epilepsy monitoring devices market include Natus Medical, Inc. (US), Compumedics Limited (Australia), Empatica, Inc. (US), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), Medtronic Plc (Ireland), Masimo Corporation (US), Boston Scientific Corporation (US), Drägerwerk AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia), Advanced Brain Monitoring (US), Lifelines Neuro Company, LLC (US), Mitsar Co., Ltd. (Russia), Rimed (US), Emotiv (US), CGX (A Cognionics Company) (US), Mindray Medical International Ltd. (China), Cadwell Industries, Inc. (US), NeuroWave Systems, Inc. (US), and MC10, Inc. (US).
Research Coverage:
The report analyzes the epilepsy monitoring devices market and aims at estimating the market size and future growth potential of this market based on various segments such as product, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on the product portfolios of the top players in the Epilepsy monitoring devices market. The report analyzes the market based on the products and region.
•Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the Epilepsy monitoring devices market.
•Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of Epilepsy monitoring devices solutions across regions.
•Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the Epilepsy monitoring devices market.
•Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the Epilepsy monitoring devices markets.

目次

1INTRODUCTION25
1.1OBJECTIVES OF THE STUDY25
1.2MARKET DEFINITION & SCOPE26
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY26
1.2.2MARKET SEGMENTATION26
FIGURE 1EPILEPSY MONITORING DEVICES MARKET SEGMENTATION26
1.2.3YEARS CONSIDERED FOR THE STUDY27
1.3CURRENCY27
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD27
1.4STAKEHOLDERS28
2RESEARCH METHODOLOGY29
2.1RESEARCH APPROACH29
2.2RESEARCH METHODOLOGY DESIGN29
FIGURE 2EPILEPSY MONITORING DEVICES MARKET: RESEARCH DESIGN29
2.2.1SECONDARY RESEARCH30
2.2.1.1Key data from secondary sources31
2.2.2PRIMARY RESEARCH32
FIGURE 3PRIMARY SOURCES32
2.2.2.1Key data from primary sources33
2.2.2.2Insights from primary experts33
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS34
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION34
2.3MARKET SIZE ESTIMATION: EPILEPSY MONITORING DEVICES MARKET35
FIGURE 6MARKET SIZE ESTIMATION: EPILEPSY MONITORING DEVICES MARKET35
FIGURE 7SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS36
FIGURE 8COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION: EPILEPSY MONITORING DEVICES MARKET36
FIGURE 9COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION: EEG MARKET37
FIGURE 10TOP-DOWN APPROACH38
FIGURE 11CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE EPILEPSY MONITORING DEVICES MARKET (2021–2026)39
FIGURE 12CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS39
2.4MARKET BREAKDOWN & DATA TRIANGULATION41
FIGURE 13DATA TRIANGULATION METHODOLOGY41
2.5MARKET SHARE ESTIMATION42
2.6ASSUMPTIONS FOR THE STUDY42
2.7LIMITATIONS43
2.7.1METHODOLOGY-RELATED LIMITATIONS43
2.7.2SCOPE-RELATED LIMITATIONS43
2.8RISK ASSESSMENT43
TABLE 2RISK ASSESSMENT: EPILEPSY MONITORING DEVICES MARKET43
3EXECUTIVE SUMMARY44
FIGURE 14EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION)44
FIGURE 15EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)45
FIGURE 16GEOGRAPHICAL SNAPSHOT OF THE EPILEPSY MONITORING DEVICES MARKET46
4PREMIUM INSIGHTS47
4.1EPILEPSY MONITORING DEVICES MARKET OVERVIEW47
FIGURE 17INCREASING INCIDENCE AND PREVALENCE OF EPILEPSY AND GROWING PREFERENCE FOR AMBULATORY HEALTHCARE AND HEALTH WEARABLES TO DRIVE MARKET GROWTH47
4.2EPILEPSY MONITORING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES48
FIGURE 18CHINA TO WITNESS THE HIGHEST GROWTH IN THE EPILEPSY MONITORING DEVICES MARKET DURING THE FORECAST PERIOD48
4.3NORTH AMERICA: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT AND COUNTRY (2020)49
FIGURE 19CONVENTIONAL DEVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN EPILEPSY MONITORING DEVICES MARKET IN 202049
4.4REGIONAL MIX: EPILEPSY MONITORING DEVICES MARKET (2021–2026)49
FIGURE 20APAC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021–2026)49
4.5EPILEPSY MONITORING DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS50
FIGURE 21DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING
THE FORECAST PERIOD50
5MARKET OVERVIEW51
5.1INTRODUCTION51
5.2MARKET DYNAMICS51
FIGURE 22EPILEPSY MONITORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES51
5.2.1DRIVERS52
5.2.1.1Increasing incidence and prevalence of epilepsy52
FIGURE 23US: RATE OF DEATH WITH EPILEPSY AS THE UNDERLYING CAUSE
(2009–2019)52
5.2.1.2Rising awareness of neurodegenerative disorders, including epilepsy53
5.2.1.3Growing preference for ambulatory healthcare and increasing use of wearables53
5.2.1.4Growing demand for continuous monitoring54
5.2.2RESTRAINTS54
5.2.2.1High cost of complex epilepsy monitoring procedures and devices54
5.2.2.2Unfavorable reimbursement policies54
5.2.3OPPORTUNITIES55
5.2.3.1Increasing demand for non-invasive and minimally invasive devices55
5.2.3.2Expanding therapeutic applications of epilepsy monitoring devices55
5.2.3.3High epilepsy incidence and growing healthcare markets in emerging economies55
FIGURE 24NUMBER OF EPILEPSY CASES IN SELECT COUNTRIES (2016)56
FIGURE 25GLOBAL ANNUAL HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING ECONOMIES (1995 VS. 2012 VS. 2022)57
5.2.4CHALLENGES57
5.2.4.1Shortage of trained professionals57
5.2.4.2Issues related to product approval and commercialization58
5.3IMPACT OF COVID-19 ON THE EPILEPSY MONITORING DEVICES MARKET58
5.4PORTER’S FIVE FORCES ANALYSIS59
FIGURE 26DEGREE OF COMPETITION IS HIGH IN THE EPILEPSY MONITORING DEVICES MARKET59
TABLE 3EPILEPSY MONITORING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS59
5.5REGULATORY ANALYSIS61
TABLE 4KEY REGULATIONS & STANDARDS GOVERNING MEDICAL DEVICES61
5.6ECOSYSTEM ANALYSIS62
FIGURE 27ECOSYSTEM ANALYSIS: EPILEPSY MONITORING DEVICES MARKET62
5.7PATENT ANALYSIS63
5.7.1PATENT PUBLICATION TRENDS63
FIGURE 28PATENT PUBLICATION TRENDS (JANUARY 2011–SEPTEMBER 2021)63
5.7.2INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS64
FIGURE 29TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR EPILEPSY MONITORING DEVICE PATENTS (JANUARY 2011–SEPTEMBER 2021)64
FIGURE 30TOP APPLICANT COUNTRIES/REGIONS FOR EPILEPSY MONITORING DEVICE PATENTS (JANUARY 2011–SEPTEMBER 2021)65
6EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT66
6.1INTRODUCTION67
TABLE 5EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)67
6.2CONVENTIONAL DEVICES67
TABLE 6COMPANIES PROVIDING CONVENTIONAL EPILEPSY MONITORING DEVICES68
TABLE 7CONVENTIONAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)68
TABLE 8CONVENTIONAL DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)69
6.2.1MONITORING DEVICES69
TABLE 9MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)70
TABLE 10MONITORING DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)70
6.2.1.1EEG devices70
TABLE 11EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)71
TABLE 12EEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)71
6.2.1.1.1Standard EEG devices72
6.2.1.1.1.1Standard EEG devices accounted for the largest share of the EEG devices market72
TABLE 13COMPANIES PROVIDING STANDARD EEG DEVICES72
TABLE 14STANDARD EEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)72
6.2.1.1.2Video EEG devices73
6.2.1.1.2.1Video EEG enables healthcare professionals to observe a patient during a seizure event and compare the visuals to the EEG results for better treatment planning73
TABLE 15COMPANIES PROVIDING VIDEO EEG DEVICES73
TABLE 16VIDEO EEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)74
6.2.1.1.3Other/Ambulatory EEG devices74
6.2.1.1.3.1Ambulatory EEG is more cost-effective and convenient in comparison with routine EEG74
TABLE 17COMPANIES PROVIDING AMBULATORY EEG DEVICES75
TABLE 18OTHER/AMBULATORY EEG DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)75
6.2.1.2EMG devices76
6.2.1.2.1High demand for EMG devices is mainly due to the increasing prevalence of neuromuscular diseases76
TABLE 19COMPANIES PROVIDING EMG DEVICES76
TABLE 20EMG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)77
6.2.1.3MEG devices77
6.2.1.3.1MEG devices are more technologically advanced than other monitoring devices as they can simultaneously measure data from several points on the surface of the head77
TABLE 21COMPANIES PROVIDING MEG DEVICES77
TABLE 22MEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)78
6.2.1.4Other monitoring devices78
TABLE 23COMPANIES PROVIDING OTHER MONITORING DEVICES78
TABLE 24OTHER MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)79
6.2.2DEEP BRAIN STIMULATION DEVICES79
6.2.2.1Successful DBS allows people to potentially reduce their medications and improve their quality of life79
TABLE 25DEEP BRAIN STIMULATION DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)80
6.3WEARABLE DEVICES80
6.3.1HIGH PREFERENCE FOR WEARABLE DEVICES DUE TO EASE OF USE IS A KEY FACTOR DRIVING MARKET GROWTH80
TABLE 26COMPANIES PROVIDING WEARABLE EPILEPSY MONITORING DEVICES81
TABLE 27WEARABLE DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)81
 
7EPILEPSY MONITORING DEVICES MARKET, BY END USER82
7.1INTRODUCTION83
TABLE 28EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)83
7.2HOSPITALS84
7.2.1HOSPITALS CAN INVEST IN EXPENSIVE AND SOPHISTICATED TECHNOLOGIES, OWING TO WHICH THE ADOPTION OF EPILEPSY MONITORING DEVICES IS HIGHER AMONG HOSPITALS84
TABLE 29EPILEPSY MONITORING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)84
7.3NEUROLOGY CENTERS85
7.3.1HIGH PREFERENCE FOR THE DIAGNOSIS AND TREATMENT OF BRAIN DISORDERS AT NEUROLOGY CENTERS IS A MAJOR FACTOR DRIVING MARKET GROWTH85
TABLE 30EPILEPSY MONITORING DEVICES MARKET FOR NEUROLOGY CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION)85
7.4AMBULATORY SURGERY CENTERS & CLINICS86
7.4.1PATIENTS ARE INCREASINGLY OPTING FOR AMBULATORY SURGERY CENTERS & CLINICS AS A MORE CONVENIENT ALTERNATIVE TO HOSPITAL-BASED OUTPATIENT PROCEDURES86
TABLE 31EPILEPSY MONITORING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)86
7.5DIAGNOSTIC CENTERS87
7.5.1DIAGNOSTIC CENTERS OFFER DIAGNOSIS AND TREATMENT OPTIONS FOR VARIOUS NEUROLOGICAL CONDITIONS—A KEY FACTOR DRIVING MARKET GROWTH87
TABLE 32EPILEPSY MONITORING DEVICES MARKET FOR DIAGNOSTIC CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION)87
7.6HOME CARE SETTINGS88
7.6.1GROWING NEED FOR LONG-TERM HOME CARE TO DRIVE MARKET GROWTH88
TABLE 33EPILEPSY MONITORING DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION)88
8EPILEPSY MONITORING DEVICES MARKET, BY REGION89
8.1INTRODUCTION90
TABLE 34EPILEPSY MONITORING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION)90
8.2NORTH AMERICA91
FIGURE 31NORTH AMERICA: EPILEPSY MONITORING DEVICES MARKET SNAPSHOT91
TABLE 35NORTH AMERICA: EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)92
TABLE 36NORTH AMERICA: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)92
TABLE 37NORTH AMERICA: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)92
TABLE 38NORTH AMERICA: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)93
TABLE 39NORTH AMERICA: EEG DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)93
TABLE 40NORTH AMERICA: EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)93
8.2.1US94
8.2.1.1The US dominates the North American epilepsy monitoring devices market94
TABLE 41US: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)94
TABLE 42US: CONVENTIONAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)95
TABLE 43US: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)95
TABLE 44US: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)95
TABLE 45US: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)96
8.2.2CANADA96
8.2.2.1Growing number of hospitals and surgical centers to drive the demand for epilepsy monitoring devices in Canada96
TABLE 46CANADA: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)96
TABLE 47CANADA: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)97
TABLE 48CANADA: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)97
TABLE 49CANADA: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)97
TABLE 50CANADA: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)98
8.3EUROPE98
TABLE 51EUROPE: EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)99
TABLE 52EUROPE: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)99
TABLE 53EUROPE: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)99
TABLE 54EUROPE: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)100
TABLE 55EUROPE: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)100
TABLE 56EUROPE: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)100
8.3.1GERMANY101
8.3.1.1High burden of Alzheimer’s in the country will support market growth101
TABLE 57GERMANY: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)101
TABLE 58GERMANY: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)101
TABLE 59GERMANY: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)102
TABLE 60GERMANY: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)102
TABLE 61GERMANY: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)102
8.3.2UK103
8.3.2.1Increasing investments by public and private sectors to drive
the growth of the epilepsy monitoring devices market in the UK103
TABLE 62UK: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)103
TABLE 63UK: CONVENTIONAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)103
TABLE 64UK: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)104
TABLE 65UK: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)104
TABLE 66UK: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)104
8.3.3FRANCE105
8.3.3.1Increasing geriatric population to drive market growth in France105
TABLE 67FRANCE: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)105
TABLE 68FRANCE: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)105
TABLE 69FRANCE: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)106
TABLE 70FRANCE: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)106
TABLE 71FRANCE: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)106
8.3.4REST OF EUROPE107
TABLE 72ROE: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)107
TABLE 73ROE: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)107
TABLE 74ROE: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)108
TABLE 75ROE: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)108
TABLE 76ROE: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)108
8.4ASIA PACIFIC109
FIGURE 32ASIA PACIFIC: EPILEPSY MONITORING DEVICES MARKET SNAPSHOT109
TABLE 77APAC: EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)110
TABLE 78APAC: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)110
TABLE 79APAC: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)110
TABLE 80APAC: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)111
TABLE 81APAC: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)111
TABLE 82APAC: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)111
8.4.1JAPAN112
8.4.1.1Incidence of epilepsy in Japan is expected to increase due to
the large geriatric population112
TABLE 83JAPAN: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)112
TABLE 84JAPAN: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)112
TABLE 85JAPAN: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)113
TABLE 86JAPAN: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)113
TABLE 87JAPAN: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)113
8.4.2CHINA114
8.4.2.1China to register the highest growth in the epilepsy monitoring devices market during the forecast period114
TABLE 88CHINA: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)114
TABLE 89CHINA: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)114
TABLE 90CHINA: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)115
TABLE 91CHINA: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)115
TABLE 92CHINA: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)115
8.4.3INDIA116
8.4.3.1Improving healthcare infrastructure in the country will support the growth of the epilepsy monitoring devices market116
TABLE 93INDIA: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)116
TABLE 94INDIA: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)116
TABLE 95INDIA: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)117
TABLE 96INDIA: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)117
TABLE 97INDIA: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)117
8.4.4REST OF ASIA PACIFIC118
TABLE 98ROAPAC: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)118
TABLE 99ROAPAC: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)118
TABLE 100ROAPAC: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)119
TABLE 101ROAPAC: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)119
TABLE 102ROAPAC: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)119
8.5REST OF THE WORLD120
TABLE 103ROW: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION)120
TABLE 104ROW: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)120
TABLE 105ROW: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)121
TABLE 106ROW: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)121
TABLE 107ROW: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)121
9COMPETITIVE LANDSCAPE122
9.1OVERVIEW122
9.2KEY PLAYER STRATEGIES/RIGHT TO WIN122
9.2.1OVERVIEW OF THE STRATEGIES ADOPTED BY PLAYERS IN THE EPILEPSY MONITORING DEVICES MARKET123
9.3COMPETITIVE BENCHMARKING124
TABLE 108FOOTPRINT OF COMPANIES IN THE EPILEPSY MONITORING DEVICES MARKET124
TABLE 109COMPANY END-USER FOOTPRINT (25 COMPANIES)125
TABLE 110COMPANY REGIONAL FOOTPRINT (26 COMPANIES)126
9.4COMPETITIVE LEADERSHIP MAPPING127
9.4.1STARS127
9.4.2EMERGING LEADERS128
9.4.3PERVASIVE PLAYERS128
9.4.4PARTICIPANTS128
FIGURE 33EPILEPSY MONITORING DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)129
9.5COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES130
9.5.1PROGRESSIVE COMPANIES130
9.5.2DYNAMIC COMPANIES130
9.5.3STARTING BLOCKS130
9.5.4RESPONSIVE COMPANIES130
FIGURE 34EPILEPSY MONITORING DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES (2020)131
9.6MARKET SHARE ANALYSIS132
FIGURE 35EPILEPSY MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2020132
TABLE 111EPILEPSY MONITORING DEVICES MARKET: DEGREE OF COMPETITION133
9.7COMPETITIVE SCENARIO134
TABLE 112PRODUCT LAUNCHES & APPROVALS, 2018–2021134
10COMPANY PROFILES136
10.1KEY PLAYERS136
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
10.1.1NATUS MEDICAL, INC.136
TABLE 114NATUS MEDICAL, INC.: BUSINESS OVERVIEW136
FIGURE 36NATUS MEDICAL, INC.: COMPANY SNAPSHOT (2020)137
10.1.2COMPUMEDICS LIMITED140
TABLE 115COMPUMEDICS LIMITED: BUSINESS OVERVIEW140
FIGURE 37COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2020)140
10.1.3NIHON KOHDEN CORPORATION143
TABLE 116NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW143
FIGURE 38NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020)144
10.1.4THE MAGSTIM CO. LTD.146
TABLE 117THE MAGSTIM CO. LTD.: BUSINESS OVERVIEW146
10.1.5MEDTRONIC PLC148
TABLE 118MEDTRONIC PLC: BUSINESS OVERVIEW148
FIGURE 39MEDTRONIC PLC: COMPANY SNAPSHOT (2020)149
10.1.6EMPATICA, INC.151
TABLE 119EMPATICA, INC.: BUSINESS OVERVIEW151
10.1.7MASIMO CORPORATION153
TABLE 120MASIMO CORPORATION: BUSINESS OVERVIEW153
FIGURE 40MASIMO CORPORATION: COMPANY SNAPSHOT (2020)153
10.1.8BOSTON SCIENTIFIC CORPORATION155
TABLE 121BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW155
FIGURE 41BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)156
10.1.9ABBOTT LABORATORIES, INC.158
TABLE 122ABBOTT LABORATORIES, INC.: BUSINESS OVERVIEW158
FIGURE 42ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT (2020)159
10.1.10ALEVA NEUROTHERAPEUTICS S.A.161
TABLE 123ALEVA NEUROTHERAPEUTICS S.A.: BUSINESS OVERVIEW161
10.1.11DRÄGERWERK AG & CO. KGAA162
TABLE 124DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW162
FIGURE 43DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2020)163
10.1.12MEDPAGE LTD.165
TABLE 125MEDPAGE LTD.: BUSINESS OVERVIEW165
10.1.13LIVASSURED B.V.166
TABLE 126LIVASSURED B.V.: BUSINESS OVERVIEW166
10.1.14MJN NEUROSERVEIS, S.L.167
TABLE 127MJN NEUROSERVEIS, S.L.: BUSINESS OVERVIEW167
10.1.15BIOSERENITY168
TABLE 128BIOSERENITY: BUSINESS OVERVIEW168
10.1.16NEUROSOFT170
TABLE 129NEUROSOFT: BUSINESS OVERVIEW170
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
10.2OTHER PLAYERS172
10.2.1ADVANCED BRAIN MONITORING, INC.172
TABLE 130ADVANCED BRAIN MONITORING, INC.: BUSINESS OVERVIEW172
10.2.2LIFELINES NEURO COMPANY, LLC173
10.2.3MITSAR CO., LTD.174
10.2.4RIMED174
10.2.5EMOTIV175
10.2.6CGX (A COGNIONICS COMPANY)175
10.2.7MINDRAY MEDICAL INTERNATIONAL LIMITED176
10.2.8CADWELL INDUSTRIES, INC.177
10.2.9NEUROWAVE SYSTEMS, INC.178
10.2.10MC10, INC.178
11APPENDIX179
11.1INSIGHTS FROM INDUSTRY EXPERTS179
11.2DISCUSSION GUIDE180
11.3KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL184
11.4AVAILABLE CUSTOMIZATIONS186
11.5RELATED REPORTS186
11.6AUTHOR DETAILS187

お問合せフォーム